MedPath

Multicenter study on the usefulness of EUS-FNB in the diagnosis of autoimmune pancreatitis

Not Applicable
Conditions
Autoimmune pancreaitis
Registration Number
JPRN-UMIN000026692
Lead Sponsor
agoya University
Brief Summary

EUS-FNB with a 22-gauge Franseen needle demonstrated favorable detection rates which would be clinically beneficial for the histological diagnosis of autoimmune pancreatitis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
56
Inclusion Criteria

Not provided

Exclusion Criteria

(1)Steroid administration within 3 months before the initiation of treatment. (2)Poorly controlled infection (including active tuberculosis). (3)Serious drug allergy. (4)Difficult in observation of the course of endoscopy. (5)Malignant tumor. (6)Serious adverse events. (7)Pregnant and lactating women, women who are possibly pregnant, and women who might want to become pregnant. (8)Severe mental disorder (9)Judgement as being ineligible by the principal or subinvestigator.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath